Related Experiment Video
Updated: Dec 20, 2025

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
Published on: June 10, 2022
Protein and mRNA Delivery Enabled by Cholesteryl-Based Biodegradable Lipidoid Nanoparticles
Yamin Li1, Rachel Jarvis2, Kuixin Zhu1
1Department of Biomedical Engineering, Tufts University, Medford, MA, 02155, USA.
Researchers developed novel biodegradable cationic lipidoid nanoparticles for delivering therapeutic biomacromolecules like mRNA and proteins. These new lipidoids demonstrate effective in vitro and in vivo delivery with reduced toxicity, offering a promising advancement in gene therapy delivery systems.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Developing safe and efficient delivery systems for therapeutic biomacromolecules (e.g., proteins, mRNA) remains a significant challenge in medicine.
- Existing delivery vectors often face limitations regarding efficacy, safety, and targeting specific tissues.
- Biodegradable and non-toxic carriers are crucial for advancing nucleic acid and protein-based therapies.
Purpose of the Study:
- To develop and characterize a novel library of cholesteryl-based, disulfide bond-containing, biodegradable cationic lipidoid nanoparticles.
- To evaluate the efficacy and safety of these novel lipidoids for in vitro and in vivo delivery of therapeutic biomacromolecules.
- To compare the performance of the newly developed lipidoids against established transfection agents.
Main Methods:
- Synthesis of a combinatorial library of cholesteryl-based, disulfide bond-containing biodegradable cationic lipidoids.
- In vitro assessment of transfection efficacy and cytotoxicity using protein and mRNA delivery models.
- In vivo studies in adult mice to evaluate biodistribution and delivery efficiency in skeletal muscle, lung, spleen, and brain following various administration routes.
Main Results:
- A subset of the developed lipidoid library demonstrated effective in vitro delivery of protein and mRNA.
- The identified lipidoids exhibited comparable transfection efficiencies to Lpf2k but with significantly lower cytotoxicity.
- Successful in vivo delivery of genome engineering proteins and mRNA was achieved in multiple organs, including muscle, lung, spleen, and brain, via different administration routes.
Conclusions:
- Cholesteryl-based, disulfide bond-containing biodegradable cationic lipidoids represent a promising new class of delivery vehicles for therapeutic biomacromolecules.
- These novel lipidoids offer a safer and effective alternative for in vitro and in vivo delivery, with potential applications in gene therapy and protein replacement.
- The demonstrated ability to deliver cargo to various tissues, including the brain, highlights the versatility of this lipidoid platform.
More Related Videos
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Receptor-mediated Endocytosis
Regulation of Nuclear Protein Sorting

